Board of Directors

Virginia Bio is led by its Board of Directors, with the participation and counsel of its Board of Advisors and Academic Council The VABIO board is comprised of 24 industry leaders from all regions of the Commonwealth of Virginia as well as an Advisory Board and an Academic Council.

Executive Commitee:

• Andrew J Krouse, Chairman of the Board
  President and CEO, Cavion
• Crystal Icenhour, Immediate Past Chairman
  CEO, Aperiomics
  
• Jeff Conroy, Immediate Past Chairman,
  CEO, Embody, LLC
• Alan Connor, Vice Chairman
  President and CEO, Cadence Inc.
  
• Carrie Roth, Treasurer
  President & CEO, Virginia Bio+Tech Park
• Ross Dunlap, Secretary
  CEO, Ceres Nanosciences
  
• James Powers, Chairman Virginia Bioscience Foundation
  CEO, HemoShear LLC

Board Members:

• Alex Euler, Director Life Science Investment, Center for Innovative Technology
  
• Thomas Frantz, Chairman Emeritus, Williams Mullen
  
• Amrie Grammer, COO & CSO, AMPEL BioSolutions
  
• Elaine Horn-Ranney, President, CEO & Co-Founder, Tympanogen
• Julie Idelkope, Vice President, U.S. State Government Relations, Pfizer
  
• Mike Innes, Partner, Pilot Health Advisors
  
• Warren Martin, Partner,Technology and Life Sciences, Cherry Bekaert, LLP
  
• John Niederhuber, CEO, Inova Translational Medicine Institute
  
• Eric Paradise, Sr. Director Partnering and Strategy, MedImmune
• Christopher Penet, Vice-President, BIO-CAT & BIO-CAT Microbials
  
• Brian Pollok, Founder & CEO,Propagenix
  
• Cynthia Rancourt, CEO, Polymer Solutions Incorporated
• Carl Sahi, President, Engineered Biopharmaceuticals, Inc.
  
• William B. Stilley, CEO, ADial Pharmaceuticals
• Rony Thomas, CEO, LifeNet Health
  
  

Legal Counsel:

• Scott Meza, Legal Counsel
  Shareholder, Greenberg Traurig, LLP

Chief Executive Officer:

Jeffrey M. Gallager, CEO Virginia Bio

VABIO Advisory Board Members:

• Brian Carney, General Partner, Harbert Venture Partners
• Frank Gilg, Independent Consultant
  
• Dan Gonzalez, Prinicipal, Avison Young
• Mickey Kim, SVP, Research & Commercialization, Inova Center for Personalized Health
• Krishna Kodukula, Ph.D., Executive Director, SRI International, Inc.
• Brandon J. Price, Ph.D.,Principal Consultant, Falcon Ridge Associates
• Marvin H. "Skip” Schuelke, President, Schuelke Biomedical Services/Laser Services
  
• Tim Stuller, Manager – Life Sciences, Virginia Economic Development Partnership
• Thomas Thorpe, CEO, Afton Scientific Corp.
• Jason Walsh
  
• Patricia B. Williams, Ph.D,. President, EyeRx Research

VABIO Academic Council:

• Barbara Boyan, Dean, School of Engineering, Virginia Commonwealth University
  
• Keith Crandall, Director, Computational Biology Institute, George Washington University
• Deborah Crawford, Vice President for Research, George Mason University
  
• Dr. Michael Friedlander, Executive Director, Virginia Tech Carilion Research Institute
• Yvonne R. Harris, Vice Provost of Research and Scholarship, James Madison University
• Dennis Manos, Ph.D., Vice Provost for Research, The College of William and Mary
• Theresa Mayer, Vice President for Research and Innovation, Virginia Tech
  
• Roy Ogle, Ph.D., Professor and Chair, Old Dominion University School of Medical Diagnostics & Translational Sciences
• Michael Straightiff, Director, U.Va Licensing & Ventures Group
  
• William J. Wasilenko, Ph.D. Associate Dean for Research, Eastern Virginia Medical School